Tectonic Therapeutics TECX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -31.4%— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 18.5×-4.4× | 26.6×+14.0× | 29.2×+19.8× | 25.6×+18.4× | 22.9×-3.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | 0×— | 0×— | 0×— | |
| Per Share | ||||||
| Book value per share | $12.28-30.0% | $13.72-17.3% | $14.30+40.0% | $15.19-73.3% | $17.55+124% | |
| Valuation | ||||||
| Market capitalization | $585.51M+58.3% | $390.42M— | $293.59M— | —— | —— | |
| Price / book | 2.5×+1.3× | 1.6×— | 1.1×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Tectonic Therapeutics's ratios come from?
- Every ratio is computed from Tectonic Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.